These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18547266)

  • 1. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis.
    Prokhorov S; Khanna S; Alapati D; Pallimalli SL
    Headache; 2008 Sep; 48(8):1235-6. PubMed ID: 18547266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information regarding subcutaneous self-administration of sumatriptan (imitrex).
    Rothrock JF
    Headache; 2007 Apr; 47(4):639. PubMed ID: 17445120
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous sumatriptan in an adolescent with acute posttraumatic headache.
    Abend NS; Nance ML; Bonnemann C
    J Child Neurol; 2008 Apr; 23(4):438-40. PubMed ID: 18182644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients.
    Rossi P; Lorenzo GD; Formisano R; Buzzi MG
    Headache; 2004; 44(7):713-8. PubMed ID: 15209695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subcutaneous sumatriptan in cluster headache: impossible mission].
    Pascual J; Laínez JM; Alberca R
    Med Clin (Barc); 1997 Feb; 108(7):278-9. PubMed ID: 9121200
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
    Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S
    Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study.
    Evers S; Gralow I; Bauer B; Suhr B; Buchheister A; Husstedt IW; Ringelstein EB
    Clin Neuropharmacol; 1999; 22(4):201-6. PubMed ID: 10442248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of paediatric migraine: a meta-analysis of efficacy.
    Silver S; Gano D; Gerretsen P
    J Paediatr Child Health; 2008 Jan; 44(1-2):3-9. PubMed ID: 17854415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable sumatriptan: now needle-based or needle-free.
    Rothrock JF
    Headache; 2010 Feb; 50(2):343-4. PubMed ID: 20456140
    [No Abstract]   [Full Text] [Related]  

  • 13. Change in frequency pattern in cluster headache induced by subcutaneous sumatriptan.
    Gupta VK
    Headache; 2005 Sep; 45(8):1089-90. PubMed ID: 16109129
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit.
    Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risks of sumatriptan administration in patients with unrecognized subarachnoid haemorrhage (SAH).
    Pfadenhauer K; Schönsteiner T; Keller H
    Cephalalgia; 2006 Mar; 26(3):320-3. PubMed ID: 16472339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The headache of SAH responds to sumatriptan.
    Rosenberg JH; Silberstein SD
    Headache; 2005 May; 45(5):597-8. PubMed ID: 15953279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of headache response in migraine treatment.
    Maas HJ; Danhof M; Della Pasqua OE
    Cephalalgia; 2006 Apr; 26(4):416-22. PubMed ID: 16556242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan.
    Jürgens TP; Busch V; Schmidt-Wilcke T; Schuierer G; Leinisch E; May A
    Cephalalgia; 2008 Mar; 28(3):302-4. PubMed ID: 18201253
    [No Abstract]   [Full Text] [Related]  

  • 19. Sumatriptan does not affect arteriovenous oxygen differences in jugular and cubital veins in normal human subjects.
    Wienecke T; Hansen JM; Petersen J; Olsen KS; Ashina M; Tfelt-Hansen P
    Cephalalgia; 2008 Oct; 28(10):1081-5. PubMed ID: 18540871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of palatal myoclonus with sumatriptan.
    Scott BL; Evans RW; Jankovic J
    Mov Disord; 1996 Nov; 11(6):748-51. PubMed ID: 8914109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.